… The prognosis is usually poor except for few such as 5q syndrome, other 5q abnormalities, …
The molecular data are reviewed and summarized in Table 2. Taken all these molecular data …

… of the molecular basis of the myelodysplastic syndromes. EVIDENCE AND … field of
myelodysplastic syndromes for several years and have contributed original papers on the molecular …

… salient features that define myelodysplastic syndromes (MDS): … a wide range of molecular
mechanisms in the pathogenesis of … targeted therapies with molecular predictors of response. …

… By combining morphologic and molecular data, these approaches will enable the identification
of nonrandom genotypic/morphologic relationships, better defining clinically relevant …

… heterogeneity of myelodysplastic syndromes (MDS) is driven by … Molecular abnormalities,
either somatic point mutations or … As the full array of molecular abnormalities is characterized, …

… Myelodysplastic syndromes (MDS) are diagnosed by a combination of cytomorphology and
… In addition, also molecular markers have been shown to contribute important information for …

… and prognostic systems that include molecular parameters should be achieved. The
integration of interconnected streams of genomic, transcriptional, and clinical data into the clinical …

… This clearly demonstrated the extent of the information being gained by molecular … Thus,
molecular data will be included in prognostication. The implementation of molecular information …

… Myelodysplastic syndromes (MDS) are characterized … data exist about decreased HOXA9
expression in MDS, but HOXA9 seems to be required for myeloid differentiation [19]. Molecular …

… still lack data on outcomes in patients with CCUS and how clinical and molecular features
… Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after …